Abstract
Rit, a member of the Ras family of GTPases, has been shown to promote cell survival in response to oxidative stress, in part by directing an evolutionarily conserved p38 MAPK-Akt survival cascade. Aberrant Rit signaling has recently been implicated as a driver mutation in human cancer, adding importance to the characterization of critical Rit effector pathways. However, the mechanism by which Rit-p38 signaling regulated Akt activity was unknown. Here, we identify mTORC2 as a critical downstream mediator of Rit-dependent survival signaling in response to reactive oxygen species (ROS) stress. Rit interacts with Sin1 (MAPKAP1), and Rit loss compromises ROS-dependent mTORC2 complex activation, blunting mTORC2-mediated phosphorylation of Akt kinase. Taken together, our findings demonstrate that the p38/mTORC2/Akt signaling cascade mediates Rit-dependent oxidative stress survival. Inhibition of this previously unrecognized cascade should be explored as a potential therapy of Rit-dependent malignancies.
| Original language | English |
|---|---|
| Article number | e115602 |
| Journal | PLoS ONE |
| Volume | 9 |
| Issue number | 12 |
| DOIs | |
| State | Published - Dec 22 2014 |
Bibliographical note
Publisher Copyright:© 2014 Cai, Andres.
Funding
| Funders | Funder number |
|---|---|
| National Institutes of Health (NIH) | |
| National Institute of Neurological Disorders and Stroke | R01NS045103 |
ASJC Scopus subject areas
- General